Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
Large Brazilian study links high artificial sweetener consumption to faster cognitive decline, raising concerns about their long-term brain health effects.
UMass Lowell on lockdown as police search for armed suspect near Riverview Suites
Sanofi's experimental eczema drug amlitelimab falls short of expectations, raising concerns about the company's ability to replace Dupixent's revenue after patent expiry.
Large Brazilian study links high artificial sweetener consumption to faster cognitive decline, raising concerns about their long-term brain health effects.
UMass Lowell on lockdown as police search for armed suspect near Riverview Suites